EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study

Clinical trial NCT00216255 · COMPLETED

Trial details

NCT number: NCT00216255
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Persistent Developmental Stuttering

Start date: 2005-04-01
Primary completion: 2011-07-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.